RAD51 and lip and oral cavity carcinoma: To study the cytotoxicity of RAD51 inhibition in oral cancer cells, RAD51 inhibitor B02 was added to OECM1 EV and OECM1 RAD51OE cells and showed dose-dependent cytotoxicity in both control and RAD51 overexpression cells.